MarketInOut Stock Screener Log In | Sign Up
 

Johnson & Johnson

MIL • Healthcare • Drug Manufacturers - General • Quote as of 07/07/2026 16:54
Johnson & Johnson stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization549,327 mln
Float2,403 mln
Earnings Date07/15/2026

EPS

7.58
Stretched

P / E

30.92
Overvalued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.08
Caution advised

Relative Strength

92 / 100
Top performer

Debt / Equity

0.68
Moderate leverage

Business Description

Founded in 1886 and headquartered in New Brunswick, New Jersey, Johnson & Johnson is a global healthcare company that develops, makes, and sells medical products across two main areas of business. The first focuses on prescription treatments for conditions ranging from cancer and heart disease to neurological disorders and lung conditions. The second supplies tools and devices used by medical professionals in surgery, joint care, eye care, and other clinical settings, including robotic surgical systems and contact lenses sold under well-known brand names.

Key Fundamentals

EPS7.58
P/E30.92
ROE26.01
RPS34.02
ROIC14.13
ROA10.58
Interest Cover24.80
EBITDA, mln28,977
EV / EBITDA19.16
EV / EBIT24.86
Revenue, mln82,818
EV / Revenue6.70

Financial Strength

Altman Z-Score3.99
Piotroski F-Score 4 / 9
Beneish M-Score-2.08
Price to Intrinsic Value2.40
Price to Lynch Fair Value2.38
Shiller PE Ratio32.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.44% 79 / 100   
1 Month 17.01% 90 / 100   
2 Months 12.04% 55 / 100   
6 Months 35.35% 81 / 100   
1 Year 88.85% 86 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us